Superficial Cervical Plexus Blockade for Clavicle Fracture Analgesia
2018年5月23日 更新者:Christopher Godlewski、University of Alabama at Birmingham
The goal of the study is to determine if the addition of a superficial cervical plexus block to a traditional interscalene plexus block will provide superior perioperative analgesia to an interscalene brachial plexus blockade alone for repair of clavicle fractures and non-/malunions.
研究概览
详细说明
When patients that are possible participants in the study present for surgery, they will be offered the opportunity to participate in the trial as part of the informed consent process.
Should they agree to participate, they will be randomized to receive either an interscalene + "sham" superficial cervical plexus block or an interscalene + superficial cervical plexus block.
The randomization will have already been predetermined based off of envelopes that will have been created by a research assistant.
Within the envelopes the proper paperwork needed to consent a participant along with a label that will be labeled either interscalene + sham superficial cervical plexus block or interscalene + superficial cervical plexus block.
This will assign the randomization of each participant (this will be unknown to all study personnel until identified by the label).
Their pain scores will be assessed pre-operatively as well as post-operatively .. If they are admitted to the hospital, the PI and/or Co-Investigators will assess their pain scores on a daily basis and follow-up with a phone call to assess their satisfaction with the block.
Numerical pain scores (scale of 0-10) will be used to assess post-operative pain with 0 indicating no pain and 10 indicating severe pain.
Post-operative pain will be assessed by compiling pain scores from 2 different sources: Numerical pain scores recorded by nursing staff (vitals section of EMR) and also pain scores ascertained by residents during rounds (progress notes).
For each pain score, we will record the date and time it was obtained.
If they are discharged the same day as surgery, they will receive a phone call within 48 hours to assess their pain scale and satisfaction.
We will also assess nausea and vomiting, the amount and type of pain medicine they are taking, and assess if they could tell when their block wore off.
研究类型
介入性
阶段
- 第三阶段
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
Alabama
-
Birmingham、Alabama、美国、35249
- UAB Department of Anesthesiology and Perioperative Medicine
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
18年 至 100年 (成人、年长者)
接受健康志愿者
是的
有资格学习的性别
全部
描述
Inclusion Criteria:
- Patients who present for repair of isolated clavicle fractures and non-/malunions that consent to regional anesthesia and to be a part of the study.
Exclusion Criteria:
- Polytraumatized patients with multiple confounding injuries, patients who are not candidates for either block at the discretion of the Anesthesia Attending, patient refusal to participate in study, patient refusal of regional technique, patients with significant pulmonary disease that will not tolerate possible hemi-diaphragmatic paralysis at the discretion of the attending anesthesiologist.
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:预防
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
假比较器:Interscalene block plus "sham"
Patients in this group will receive a traditional interscalene block and a "sham" superficial plexus block with ropivacaine and 5-10cc of normal saline.
N = 20
|
0.5% of Ropivacaine will be used patients in both groups.
Ropivacaine is very common in the investigator's practice of regional anesthesia.
The investigator has experienced minimal adverse effects with 0.5% Ropivacaine used in volume suggested in our study.
其他名称:
5-10cc of Normal Saline will be given to patients receiving a traditional interscalene block and a sham superficial plexus block.
其他名称:
|
|
有源比较器:Interscalene plus superficial plexus block
Patients in this group will receive a traditional interscalene block and a superficial plexus block with ropivacaine .
N = 20
|
0.5% of Ropivacaine will be used patients in both groups.
Ropivacaine is very common in the investigator's practice of regional anesthesia.
The investigator has experienced minimal adverse effects with 0.5% Ropivacaine used in volume suggested in our study.
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Pain Score
大体时间:baseline to 48 hours postoperatively
|
Average pain score from baseline to 48 hrs postoperatively
|
baseline to 48 hours postoperatively
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Patient Satisfaction
大体时间:48 hours postoperatively
|
Patient satisfaction score at 48 hours postoperatively
|
48 hours postoperatively
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 首席研究员:Christopher A Godlewski, MD、University of Alabama at Birmingham
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (预期的)
2018年4月1日
初级完成 (预期的)
2018年7月1日
研究完成 (预期的)
2018年12月1日
研究注册日期
首次提交
2017年6月13日
首先提交符合 QC 标准的
2017年6月13日
首次发布 (实际的)
2017年6月15日
研究记录更新
最后更新发布 (实际的)
2018年5月25日
上次提交的符合 QC 标准的更新
2018年5月23日
最后验证
2018年5月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.
Ropivacaine的临床试验
-
Fudan University尚未招聘乳腺肿瘤 | 麻醉,局部 | 外科手术,手术 | 肺通气 | 肋间神经阻滞
-
The Affiliated Hospital of Putian University尚未招聘
-
Chengdu Jinjiang Maternity and Child Health Hospital尚未招聘